Key facts
- The Good Bug’s last known valuation is $60.6M (May 2025).
- It has raised $15.2M; the latest was Early Stage VC ($11.7M) in May 2025.
- Notable investors include Fireside Ventures, Alphatron Capital, Sharrp Ventures, Harsh Mariwala, SIG Venture Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for The Good Bug
- ·The full record, as it builds
Funding rounds
No funding rounds for The Good Bug are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About The Good Bug
Producer of water-soluble probiotics intended to improve overall core health, gut health and daily wellness. The company offers a wide range of products for weight management, bloating and gas, constipation, reproductive health, immunity and sleep, enabling users to have access to healthcare products.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Mumbai, India
- Founded
- 2021
- Employees
- 70
- Website
- thegoodbug.com/
- Ownership
- Privately Held (backing)
The Good Bug doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in The Good Bug shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on The Good Bug in its N-PORT filings yet. We sweep new filings monthly.